-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Regenerx Biopharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2018 to Q1 2023.
- Regenerx Biopharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
- Regenerx Biopharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was $0.000.
- Regenerx Biopharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was $0.000.
- Regenerx Biopharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was $0.000.
- Regenerx Biopharmaceuticals Inc annual Income Tax Expense (Benefit) for 2020 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)